{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_296fd018ed14f3d7a47dd32753da1088186e7641cd93732a13d1df4b0e0ee692","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_296fd018ed14f3d7a47dd32753da1088186e7641cd93732a13d1df4b0e0ee692","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"3d0d2f6167e3b8bd8a2028e9ffd54f45de4954a91230bcd99431f078ecfdd5cb","published":"Sat, 06 Jun 2026 00:00:00 -0400","receipt_hash":"3d0d2f6167e3b8bd8a2028e9ffd54f45de4954a91230bcd99431f078ecfdd5cb","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"3d0d2f6167e3b8bd8a2028e9ffd54f45de4954a91230bcd99431f078ecfdd5cb","observed_at":"2026-06-06T04:43:19.193968Z","parent_run_hash":"550d5b02674822f43975c282be668ca76a4d9c7c957eb1601ba8b07dcb67715e","published":"Sat, 06 Jun 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2606.06201v1 Announce Type: new \nAbstract: Pharmaceutical supply chains (PSCs) struggle with inventory management (IM) due to unpredictable demand patterns and variable lead times associated with restocking. This complexity is further compounded by the finite shelf lives of pharmaceutical products, which necessitate a delicate balance between adequate stock and minimal waste. These intertwined factors create a complex optimization problem that requires sophisticated inventory strategies to ensure both product availability and PSC efficiency. This study aims to develop an optimal inventory replenishment policy for pharmaceutical products that can handle the stochasticity arising from uncertain demand and variable PSC conditions. The objective is to maximize the profitability of the PSC while maintaining a high patient service level. We formulate the problem as a Markov decision process and propose a deep reinforcement learning (DRL) approach, specifically, a hybrid asynchronous ad","title":"Learning to replenish: A hybrid deep reinforcement learning for dynamic inventory management in the pharmaceutical supply chains","url":"https://arxiv.org/abs/2606.06201","vendor":"arxiv_cs_ai"},"summary":"arXiv:2606.06201v1 Announce Type: new \nAbstract: Pharmaceutical supply chains (PSCs) struggle with inventory management (IM) due to unpredictable demand patterns and variable lead times associated with restocking. This complexity is further compounded by the finite shelf lives of pharmaceutical products, which necessitate a delicate balance between adequate stock and minimal waste. These intertwined factors create a complex optimization problem that requires sophisticated inventory strategies to ensure both product availability and PSC efficiency. This study aims to develop an optimal inventory replenishment policy for pharmaceutical products that can handle the stochasticity arising from uncertain demand and variable PSC conditions. The objective is to maximize the profitability of the PSC while maintaining a high patient service level. We formulate the problem as a Markov decision process and propose a deep reinforcement learning (DRL) approach, specifically, a hybrid asynchronous ad","title":"Learning to replenish: A hybrid deep reinforcement learning for dynamic inventory management in the pharmaceutical supply chains","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-06-06T04:43:19Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2606.06201"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:154c616557a7e46f78178a047b473bccfa692bcb1e529121c95075a3500192290913e7183e2c8aceab502fc6bd1d411760bdfe01321dcefaa4e16de669928900","signer":"crovia.substrate","subject":{"observed_at":"2026-06-06T04:43:19Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2606.06201"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"b82c924a9663e35c9763740343170140ce395aaac32f27e353b4ea6cf82f18f8","leaf_index":219222,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"21ae9c218fbee09ed1ad21a83e7df14aa95dbcf6d7ee646eff5e4c82ac57dc6b","side":"right"},{"sibling":"5d05d039f19d99f7bb7a94e8881f03ff56178afbef298c8ebd0ac09a7699b7ec","side":"left"},{"sibling":"e63ef64879141ad4b11c2dc3dc4e4fa5b7b836fffe7036391977afb42b476d1e","side":"left"},{"sibling":"fd9575f6a948714c1130b95611448d61f4fdc06ee3fa9ceac87178a2637d6086","side":"right"},{"sibling":"c0616cd686a7d38739929a6b6198928931be6abaab4234cb997a6de4159373b3","side":"left"},{"sibling":"54a29ea507e360ebe80a86f0756bc1afaf2a0bae92bafa210f0b67fa7c7e821e","side":"right"},{"sibling":"63213cfb37562a3ef2d70c7ab846d4203323a4985a9908a7078e73d8d4ab2f65","side":"left"},{"sibling":"8f35ffd1b994bec37a9cc24e0047790f92b64b006d85bef48f319d6d28a40687","side":"right"},{"sibling":"bd0dfa76bed61a2c5e95135a7304a2b8c4fd064958dbf768664232880d0abaa5","side":"right"},{"sibling":"84d2509eab51047589142ed6da8c496305d2fbcbe148e0e6755163db2c7a4bc4","side":"right"},{"sibling":"9e3ea17e834fab022f2eabcfedb8ea0ac95c1f9fb57edc5004dded68522d3c9e","side":"right"},{"sibling":"41d58fea95a95071715ee23ef8bcd15f5867a3639da28e62a0641bc95eb83094","side":"left"},{"sibling":"27ad9d6a9ab792d708709017242a61b9ca519da4e035f87a342811aae221d000","side":"left"},{"sibling":"5f303e2a7840c60038ff2d035b1cd911feefb0fba880de2d737c6671ace594d4","side":"right"},{"sibling":"b2590791b920ca2a4ed39de126d2c0b1a10d9e7e62f572f12425f214e767b6e1","side":"left"},{"sibling":"1a61eadbf0217d063ab78291ccafdc0c92907f7d6ccdc3357534ef89f07d78ae","side":"right"},{"sibling":"c300cf0154c136afc09b1702a0be98f4ba5b6dc5cf57e8cc714ec1eaf4196eff","side":"left"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":219672,"merkle_root":"d3e32d3a61ca02ce6b1f0b2db86721107770b250e8a5bf762a2c225d2f03c870","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260606T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-06-06T05:38:35Z","sig_algorithm":"ed25519","signature":"dab214c2d4d857f01383c8e93a521a774b1aba60eaee5677d4e43e4074f0342b2c6a9b9bfcff0eba74f7ac81fcb490dd0e43727979c1a7e8979c7e11547fb101","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_296fd018ed14f3d7a47dd32753da1088186e7641cd93732a13d1df4b0e0ee692"}}